Portfolio company
Salvia
Netherlands · £47.4m raised
Raised
£47.4m
Latest stage
Series B
Rounds recorded
1
Backed by
1 investor
Sectors
About
The company develops minimally invasive, ultra-thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraines.
SourceFunding history · 1
Similar companies
Salvia BioElectronics
This company develops thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraine and other neurological conditions.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
heyvie
This company develops a digital application providing neurocentric exercises and tracking tools for individuals suffering from migraines.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
Neurobioniocs
The company develops flexible bioelectronic fibers that deliver neuromodulation therapy through blood vessels for patients with neurological disorders.
Inner Cosmos
This company develops a minimally invasive brain-computer interface implant to treat cognitive disorders for patients suffering from depression.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Migrevention
This digital health company develops a digital headache clinic comprising a patient diary application and specialist dashboard for monitoring and treating migraine patients.
